Paramedic Initiated Lisinopril For Acute Stroke Treatment
NCT01066572 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2017-03-30
Summary
This study aims to investigate the use of lisinopril to lower blood pressure in stroke patients, pre-hospital, by research-trained paramedics.
Conditions
Interventions
- DRUG
-
Lisinopril
5-10 mg Lisinopril per day for seven days, depending on blood pressure.
- DRUG
-
Matched placebo; identical tablets to Lisinopril.
Sponsors & Collaborators
-
North East Ambulance Service NHS Foundation Trust
collaborator OTHER -
Northumbria Healthcare NHS Foundation Trust
collaborator OTHER -
Newcastle-upon-Tyne Hospitals NHS Trust
lead OTHER
Principal Investigators
-
Christopher Price · Northumbria Healthcare NHS Foundation Trust
-
Anand Dixit · Newcastle-upon-Tyne Hospitals NHS Trust
-
Ann Fox · North East Ambulance Service NHS Foundation Trust
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
NCT06196320 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT01104467 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Nitric Oxide in Stroke (ENOS) Trial
NCT00989716 ·Status: UNKNOWN ·Phase: PHASE3
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke
NCT00123305 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China
NCT06078995 ·Status: RECRUITING
-
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
NCT00283088 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642 ·Status: RECRUITING ·Phase: PHASE2
-
Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)
NCT01422616 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study
NCT06194968 ·Status: RECRUITING
-
Stroke Treatment With Acute Reperfusion and Simvastatin
NCT01073007 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Effectiveness and Safety of Nitrone for Injection in Patients With Acute Ischemic Stroke
NCT04951440 ·Status: UNKNOWN ·Phase: NA
-
Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke
NCT04918719 ·Status: COMPLETED ·Phase: PHASE2
-
Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke
NCT04733742 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke
NCT03686163 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
NCT01955707 ·Status: COMPLETED ·Phase: PHASE2
-
Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial
NCT03772847 ·Status: COMPLETED ·Phase: PHASE4
-
Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke
NCT00663338 ·Status: COMPLETED ·Phase: PHASE2
-
Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke
NCT02149875 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users
NCT07092709 ·Status: RECRUITING ·Phase: PHASE3
-
STROKE 120 ACTION Trial
NCT07135310 ·Status: NOT_YET_RECRUITING ·Phase: NA